| Year |
Title |
Altmetric |
| 2023
|
Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5.
Obesity.
31:703-715.
2023
|
|
| 2023
|
Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association’s Strategically Focused Research Network.
Journal of the American Heart Association.
12.
2023
|
|
| 2023
|
Clinical and Cost Benefits of Anti-Obesity Medication for US Veterans Participating in the MOVE! Weight Management Program.
Population Health Management.
26:72-82.
2023
|
|
| 2023
|
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses
2023
|
|
| 2023
|
Burden of illness associated with overweight and obesity in patients hospitalized with COVID-19 in the United States: analysis of the premier healthcare database from April 1, 2020 to October 31, 2020
2023
|
|
| 2023
|
Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials.
EClinicalMedicine.
55.
2023
|
|
| 2022
|
Associations Among Physical Activity, Adiposity, and Insulin Resistance in Children Exposed In Utero to Maternal Obesity With and Without Gestational Diabetes..
Pediatric Exercise Science.
1-9.
2022
|
|
| 2022
|
Epigenetic Age Acceleration in Mothers and Offspring 4–10 Years after a Pregnancy Complicated by Gestational Diabetes and Obesity.
Metabolites.
12.
2022
|
|
| 2022
|
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
2022
|
|
| 2022
|
Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
Journal of managed care & specialty pharmacy.
28:1066-1079.
2022
|
|
| 2022
|
Mother-child cardiometabolic health 4–10 years after pregnancy complicated by obesity with and without gestational diabetes
2022
|
|
| 2022
|
Examining the evidence for weight management in individuals with type 2 diabetes
2022
|
|
| 2022
|
Associations between cardiometabolic disease severity, social determinants of health (SDoH), and poor COVID-19 outcomes.
Obesity.
30:1483-1494.
2022
|
|
| 2022
|
Race Versus Social Determinants of Health in COVID-19 Hospitalization Prediction.
American Journal of Preventive Medicine.
63:S103-S108.
2022
|
|
| 2022
|
French-fried potato consumption and energy balance: A randomized controlled trial.
American Journal of Clinical Nutrition.
115:1626-1636.
2022
|
|
| 2022
|
American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings: Co-Sponsored by the American Association for the Study of Liver Diseases (AASLD)
2022
|
|
| 2022
|
New Horizons. A New Paradigm for Treating to Target with Second-Generation Obesity Medications..
Journal of Clinical Endocrinology and Metabolism.
107:e1339-e1347.
2022
|
|
| 2022
|
Is Obesity or Adiposity-Based Chronic Disease Curable: The Set Point Theory, the Environment, and Second-Generation Medications
2022
|
|
| 2022
|
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults with Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
Journal of the American Medical Association.
327:138-150.
2022
|
|
| 2022
|
Household Disorder and Blood Pressure in Mother–Child Dyads: A Brief Report.
Journal of Personality and Social Psychology.
2022
|
|
| 2022
|
Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial.
Nature Medicine.
2022
|
|
| 2021
|
Case presentation and panel discussion: Cardiometabolic risk mitigation.
Journal of Parenteral and Enteral Nutrition.
45:93-99.
2021
|
|
| 2021
|
Building Successful Models in Primary Care to Improve the Management of Adult Patients with Obesity.
Population Health Management.
24:548-559.
2021
|
|
| 2021
|
Sex and race contribute to variation in mitochondrial function and insulin sensitivity.
Physiological Reports.
9.
2021
|
|
| 2021
|
Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy and Body Weight in Adults with Overweight or Obesity - Reply.
Journal of the American Medical Association.
326:1214-1215.
2021
|
|
| 2021
|
Genetic landscape of Gullah African Americans.
American Journal of Physical Anthropology.
175:905-919.
2021
|
|
| 2021
|
Long-term health benefits of intensive lifestyle intervention in the Look AHEAD study.
Obesity.
29:1242-1243.
2021
|
|
| 2021
|
Serum urate and cardiovascular events in the DCCT/EDIC study.
Scientific Reports.
11:14182.
2021
|
|
| 2021
|
Arterial Stiffness: Comment on the Article by Pavloska et al
2021
|
|
| 2021
|
Exercise training and diet-induced weight loss increase markers of hepatic bile acid (BA) synthesis and reduce serum total BA concentrations in obese women
2021
|
|
| 2021
|
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Journal of the American Medical Association.
325:1403-1413.
2021
|
|
| 2020
|
Diagnosing Obesity as a First Step to Weight Loss: An Observational Study.
Obesity.
28:2305-2309.
2020
|
|
| 2020
|
Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women.
Physiological Reports.
8.
2020
|
|
| 2020
|
Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
PLoS Medicine.
17.
2020
|
|
| 2020
|
COVID-19 & obesity: Beyond BMI
2020
|
|
| 2020
|
Erratum: Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: Impact of a fitness and weight loss intervention (American Journal of Physiology - Endocrinology and Metabolism (2019) 317 (E999-E1014) DOI: 10.1152/ajpendo.00091.2019)
2020
|
|
| 2020
|
In utero nutritional stress as a cause of obesity: Altered relationship between body fat, leptin levels and caloric intake in offspring into adulthood.
Life Sciences.
254.
2020
|
|
| 2020
|
Response to “The Future of Obesity Diagnostic Coding”.
Obesity.
28:1169-1170.
2020
|
|
| 2020
|
Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5.
Obesity.
28:1050-1061.
2020
|
|
| 2020
|
Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes.
International Journal of Obesity.
44:990-998.
2020
|
|
| 2020
|
Efficacy and safety of liraglutide 3.0 mg in individuals with overweight or obesity and type 2 diabetes treated with basal insulin: The SCALE insulin randomized controlled trial.
Diabetes reviews (Alexandria, Va.).
43:1085-1093.
2020
|
|
| 2020
|
Proposal for a Scientifically Correct and Medically Actionable Disease Classification System (ICD) for Obesity.
Obesity.
28:484-492.
2020
|
|
| 2020
|
Race affects the association of obesity measures with insulin sensitivity.
American Journal of Clinical Nutrition.
111:515-525.
2020
|
|
| 2020
|
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps: JACC State-of-the-Art Review.
Journal of the American College of Cardiology.
75:539-555.
2020
|
|
| 2020
|
Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-of-the-Art Review.
Journal of the American College of Cardiology.
75:525-538.
2020
|
|
| 2020
|
Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.
Surgery for Obesity and Related Diseases.
16:175-247.
2020
|
|
| 2020
|
Consensus statement by the American Association of clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm - 2020 executive summary
2020
|
|
| 2019
|
Clinical Practice Guidelines For The Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures – 2019 Update: Cosponsored By American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society For Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists
2019
|
|
| 2019
|
Core Principles, Treatment Standards, and Provider Competencies for the Care of Patients with Obesity.
Obesity.
27:1045-1047.
2019
|
|
| 2019
|
Testosterone therapy in men with hypogonadism prevents progression from prediabetes to type 2 diabetes: Eight-year data from a registry study.
Diabetes reviews (Alexandria, Va.).
42:1104-1111.
2019
|
|
| 2019
|
Commentary from the American association of clinical endocrinologists on the U.S. preventive services task force recommandations regarding weight loss interventions
2019
|
|
| 2019
|
The diagnosis and evaluation of patients with obesity
2019
|
|
| 2019
|
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm – 2019 executive summary
2019
|
|
| 2019
|
Exercise plasma metabolomics and xenometabolomics in obese, sedentary, insulin-resistant women: Impact of a fitness and weight loss intervention
2019
|
|
| 2019
|
Nutrition therapy for adults with diabetes or prediabetes: A consensus report.
Diabetes reviews (Alexandria, Va.).
42:731-754.
2019
|
|
| 2019
|
Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: A hypothesis-generating prospective study of cardiovascular events in T1D.
Journal of Lipid Research.
60:1432-1439.
2019
|
|
| 2018
|
Dysglycemia-based chronic disease: An American association of clinical endocrinologists position statement
2018
|
|
| 2018
|
Effects of canagliflozin versus glimepiride on adipokines and inflammatory biomarkers in type 2 diabetes
2018
|
|
| 2018
|
Improved systemic metabolism and adipocyte biology in miR-150 knockout mice
2018
|
|
| 2018
|
Leptin, An Adipokine With Central Importance in the Global Obesity Problem.
Global Heart.
13:113-127.
2018
|
|
| 2018
|
The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis.
Journal of Dermatological Science.
90:343-356.
2018
|
|
| 2018
|
Oxidative stress and cardiovascular risk in type 1 diabetes mellitus: Insights from the DCCT/EDIC study.
Journal of the American Heart Association.
7.
2018
|
|
| 2018
|
Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans.
Metabolic Syndrome and Related Disorders.
16:82-89.
2018
|
|
| 2018
|
Effect of Lorcaserin Alone and in Combination with Phentermine on Food Cravings After 12-Week Treatment: A Randomized Substudy.
Obesity.
26:332-339.
2018
|
|
| 2018
|
Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.
Journal of Lipid Research.
59:872-883.
2018
|
|
| 2018
|
Application of the AACE/ACE advanced framework for the diagnosis of obesity and cardiometabolic disease staging in a general population from 3 regions of Venezuela: The vemsols study results
2018
|
|
| 2018
|
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary
2018
|
|
| 2017
|
Obesity and cardiometabolic disease -more than meets the eye.
Nature Reviews Endocrinology.
13:566-568.
2017
|
|
| 2017
|
Impact of common genetic determinants of Hemoglobin A1c on type 2 diabetes risk and diagnosis in ancestrally diverse populations: A transethnic genome-wide meta-analysis.
PLoS Medicine.
14.
2017
|
|
| 2017
|
Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: Pooled results from phase III clinical trials assessing phentermine/topiramate extended release.
Diabetes reviews (Alexandria, Va.).
40:856-862.
2017
|
|
| 2017
|
To the editor: Author response to Dr. Zhu
2017
|
|
| 2017
|
Childhood maltreatment is an independent risk factor for prediabetic disturbances in glucose regulation.
Frontiers in Endocrinology.
8.
2017
|
|
| 2017
|
Letter to the Editor
2017
|
|
| 2017
|
Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.
Obesity.
25:857-865.
2017
|
|
| 2017
|
F2-Isoprostanes Reflect Oxidative Stress Correlated With Lean Mass and Bone Density but Not Insulin Resistance..
Journal of the Endocrine Society.
1:436-448.
2017
|
|
| 2017
|
Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial.
Journal of Diabetes and Its Complications.
31:891-897.
2017
|
|
| 2017
|
Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress
2017
|
|
| 2017
|
Pharmacotherapy for Weight Management in the VHA.
Journal of General Internal Medicine.
32:70-73.
2017
|
|
| 2017
|
Reply: Role of Adiponectin: Important or Null?.
Journal of the American College of Cardiology.
69:1518-1519.
2017
|
|
| 2017
|
Adiposity-based chronic disease as a new diagnostic term: The American association of clinical endocrinologists and American college of endocrinology position statement
2017
|
|
| 2017
|
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY
2017
|
|
| 2017
|
Update and next steps for real-world translation of interventions for type 2 diabetes prevention: Reflections from a diabetes care editors' expert forum. Diabetes care 2016;39:1186-1201.
Diabetes reviews (Alexandria, Va.).
40:e21-e22.
2017
|
|
| 2017
|
Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons.
Experimental Physiology.
102:48-69.
2017
|
|
| 2016
|
Patient-centered care of the patient with obesity
2016
|
|
| 2016
|
Effects of liraglutide 3.0 mg on weight and risk factors in hispanic versus non-hipanic populations: Subgroup analysis from scale randomized trials
2016
|
|
| 2016
|
Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes.
Obesity.
24:2269-2277.
2016
|
|
| 2016
|
The Adipokine-Cardiovascular-Lifestyle Network: Translation to Clinical Practice.
Journal of the American College of Cardiology.
68:1785-1803.
2016
|
|
| 2016
|
Glycemic Control and Urinary Tract Infections in Women with Type 1 Diabetes: Results from the DCCT/EDIC.
Investigative urology.
196:1129-1135.
2016
|
|
| 2016
|
The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.
Molecular Genetics and Genomic Medicine.
4:548-556.
2016
|
|
| 2016
|
Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders.
Postgraduate medicine.
128:591-597.
2016
|
|
| 2016
|
Skeletal muscle TRIB3 mediates glucose toxicity in diabetes and high-fat diet-induced insulin resistance.
Diabetes.
65:2380-2391.
2016
|
|
| 2016
|
Trends in Cardiovascular Health Metrics in Obese Adults: National Health and Nutrition Examination Survey (NHANES), 1988-2014.
Journal of the American Heart Association.
5.
2016
|
|
| 2016
|
AP2-NR4A3 transgenic mice display reduced serum epinephrine because of increased catecholamine catabolism in adipose tissue
2016
|
|
| 2016
|
American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity: Executive summary
2016
|
|
| 2016
|
Significance of epicardial and intrathoracic adipose tissue volume among type 1 diabetes patients in the DCCT/EDIC: A pilot study.
PLoS One.
11.
2016
|
|
| 2016
|
Do glycemic marker levels vary by race? Differing results from a cross-sectional analysis of individuals with and without diagnosed diabetes
2016
|
|
| 2016
|
Transculturalization recommendations for developing Latin American clinical practice algorithms in endocrinology - Proceedings of the 2015 pan-American workshop by the American association of clinical endocrinologists and American college of endocrinology
2016
|
|
| 2016
|
Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
Data in Brief.
6:33-38.
2016
|
|
| 2016
|
Deletion of the toll-like receptor 5 gene per se does not determine the gut microbiome profile that induces metabolic syndrome: Environment trumps genotype.
PLoS One.
11.
2016
|
|
| 2016
|
Cardiometabolic disease risk in metabolically healthy and unhealthy obesity: Stability of metabolic health status in adults.
Obesity.
24:516-525.
2016
|
|
| 2016
|
Tribbles Homolog 3 Promotes Foam Cell Formation Associated with Decreased Proinflammatory Cytokine Production in Macrophages: Evidence for Reciprocal Regulation of Cholesterol Uptake and Inflammation.
Metabolic Syndrome and Related Disorders.
14:7-15.
2016
|
|
| 2016
|
Ablation of the duodenal mucosa as a strategy for glycemic control in type 2diabetes: Role of nutrient signaling or simple weight loss.
Diabetes reviews (Alexandria, Va.).
39:2108-2110.
2016
|
|
| 2016
|
American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity
2016
|
|
| 2016
|
Consensus statement by the American association of clinical endocrinologists and American college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2016 executive summary
2016
|
|
| 2016
|
Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes.
Atherosclerosis.
244:93-100.
2016
|
|
| 2016
|
Weight maintenance: Challenges, tools and strategies for primary care physicians.
Obesity Reviews.
17:81-93.
2016
|
|
| 2015
|
Consensus statement by the American association of clinical endocrinologists and American College of endocrinology on the comprehensive type 2 diabetes management algorithm - 2015 executive summary
2015
|
|
| 2015
|
AACE response to a candid discussion of obesity.
American Journal of Medicine.
128:e57.
2015
|
|
| 2015
|
Development of a weighted cardiometabolic disease staging (CMDS) system for the prediction of future diabetes.
Journal of Clinical Endocrinology and Metabolism.
100:3871-3877.
2015
|
|
| 2015
|
Advances in the science, treatment, and prevention of the disease of obesity: Ref lections from a diabetes care editors' expert forum.
Diabetes reviews (Alexandria, Va.).
38:1567-1582.
2015
|
|
| 2015
|
American Association of Clinical Endocrinologists and American College of Endocrinology - Clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
2015
|
|
| 2015
|
Challenging obesity: Patient, provider, and expert perspectives on the roles of available and emerging nonsurgical therapies.
Obesity.
23:S1-S26.
2015
|
|
| 2015
|
The conundrum of whole foods versus macronutrient composition in assessing effects on insulin sensitivity.
American Journal of Clinical Nutrition.
101:1109-1110.
2015
|
|
| 2015
|
Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action.
Current Obesity Reports.
4:287-302.
2015
|
|
| 2015
|
AACE/ACE comprehensive diabetes management algorithm 2015
2015
|
|
| 2015
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY
2015
|
|
| 2015
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN - 2015.
2015
|
|
| 2015
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY
2015
|
|
| 2015
|
KSRP is critical in governing hepatic lipid metabolism through controlling Per2 expression.
Journal of Lipid Research.
56:227-240.
2015
|
|
| 2014
|
Weight-loss therapy in type 2 diabetes: Effects of phentermine and topiramate extended release.
Diabetes reviews (Alexandria, Va.).
37:3309-3316.
2014
|
|
| 2014
|
Lipoprotein insulin resistance index: A lipoprotein particle-derived measure of insulin resistance.
Metabolic Syndrome and Related Disorders.
12:422-429.
2014
|
|
| 2014
|
American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.
2014
|
|
| 2014
|
American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease.
2014
|
|
| 2014
|
Insulin exerts direct, IGF-1 independent actions in growth plate chondrocytes.
Bone Research.
2.
2014
|
|
| 2014
|
Use of HbA1c for diagnoses of diabetes and prediabetes: Comparison with diagnoses based on fasting and 2-Hr glucose values and effects of gender, race, and age.
Metabolic Syndrome and Related Disorders.
12:258-268.
2014
|
|
| 2014
|
BMI, RQ, diabetes, and sex affect the relationships between amino acids and clamp measures of insulin action in humans.
Diabetes.
63:791-800.
2014
|
|
| 2014
|
Improved metabolic health alters host metabolism in parallel with changes in systemic xeno-metabolites of gut origin.
PLoS One.
9.
2014
|
|
| 2014
|
Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes.
Hormone and Metabolic Research.
46:341-347.
2014
|
|
| 2014
|
Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: Project SuGAR.
Southern Medical Journal.
107:607-614.
2014
|
|
| 2014
|
Influence of acute hyperlipidemia to adipocyte-derived hormones in lean normotensive and subjects with metabolic syndrome.
Diabetology and Metabolic Syndrome.
6.
2014
|
|
| 2014
|
KSRP ablation enhances brown fat gene program in white adipose tissue through reduced miR-150 expression.
Diabetes.
63:2949-2961.
2014
|
|
| 2014
|
Novel effects of Brefeldin A (BFA) in signaling through the insulin receptor (IR) pathway and regulating FoxO1-mediated transcription..
Cellular Logistics.
4:e27732.
2014
|
|
| 2014
|
Plasma total homocysteine and carotid intima-media thickness in type 1 diabetes: A prospective study.
Atherosclerosis.
236.
2014
|
|
| 2014
|
Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.
Diabetes reviews (Alexandria, Va.).
37:912-921.
2014
|
|
| 2014
|
The progression of cardiometabolic disease: Validation of a new cardiometabolic disease staging system applicable to obesity.
Obesity.
22:110-118.
2014
|
|
| 2013
|
TRIB3 mediates glucose-induced insulin resistance via a mechanism that requires the hexosamine biosynthetic pathway.
Diabetes.
62:4192-4200.
2013
|
|
| 2013
|
6-Mercaptopurine augments glucose transport activity in skeletal muscle cells in part via a mechanism dependent upon orphan nuclear receptor NR4A3
2013
|
|
| 2013
|
Erratum: AACE Obesity Position Statement (Endocrine Practice (2012) 18 (642-648))
2013
|
|
| 2013
|
Type 2 diabetes with partial lipodystrophy of the limbs: A new lipodystrophy phenotype.
Diabetes reviews (Alexandria, Va.).
36:2247-2253.
2013
|
|
| 2013
|
A complications-based clinical staging of obesity to guide treatment modality and intensity.
Current Opinion in Endocrinology, Diabetes and Obesity.
20:377-388.
2013
|
|
| 2013
|
Apolipoprotein-defined lipoproteins and apolipoproteins: Associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort.
Journal of Diabetes and Its Complications.
27:447-453.
2013
|
|
| 2013
|
Clinical practice guidelines for healthy eating for the prevention and treatment of metabolic and endocrine diseases in adults: Cosponsored by the American association of clinical endocrinologists/the american college of endocrinology and the obesity society: Executive summary
2013
|
|
| 2013
|
New options for the treatment of obesity and type 2 diabetes mellitus (narrative review).
Journal of Diabetes and Its Complications.
27:508-518.
2013
|
|
| 2013
|
New tools for weight-loss therapy enable a more robust medical model for obesity treatment: Rationale for a complications-centric approach
2013
|
|
| 2013
|
Phentermine and topiramate extended-release: A new treatment for obesity and its role in a complications-centric approach to obesity medical management.
Expert Opinion on Drug Safety.
12:741-756.
2013
|
|
| 2013
|
Genome-Wide Association of Body Fat Distribution in African Ancestry Populations Suggests New Loci.
PLoS Genetics.
9.
2013
|
|
| 2013
|
A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.
Nature Genetics.
45:690-696.
2013
|
|
| 2013
|
American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement
2013
|
|
| 2013
|
Enhanced adiponectin actions by overexpression of adiponectin receptor 1 in macrophages.
Atherosclerosis.
228:124-135.
2013
|
|
| 2013
|
AdR1-TG/TALLYHO mice have improved lipid accumulation and insulin sensitivity.
Biochemical and Biophysical Research Communications.
433:567-572.
2013
|
|
| 2013
|
Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: Impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans.
Diabetes reviews (Alexandria, Va.).
36:845-853.
2013
|
|
| 2013
|
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient - 2013 update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery.
Surgery for Obesity and Related Diseases.
9:159-191.
2013
|
|
| 2013
|
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Society for Metabolic & Bariatric Surgery
2013
|
|
| 2013
|
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: Cosponsored by American association of clinical endocrinologists, the obesity society, and American society for metabolic & bariatric surgery.
Obesity.
21.
2013
|
|
| 2013
|
VPO1 Mediates ApoE Oxidation and Impairs the Clearance of Plasma Lipids.
PLoS One.
8.
2013
|
|
| 2013
|
AACE comprehensive diabetes management algorithm 2013.
2013
|
|
| 2013
|
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.
2013
|
|
| 2013
|
In response
2013
|
|
| 2013
|
Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3.
Hormone and Metabolic Research.
45:213-220.
2013
|
|
| 2013
|
The clinical approach to the detection of lipodystrophy - An AACE consensus statement
2013
|
|
| 2013
|
The impact of weight loss among seniors on medicare spending.
Health Economics Review.
3:1-6.
2013
|
|
| 2013
|
Use of available glucose-lowering agents in patients with different levels of renal impairment
2013
|
|
| 2012
|
Gene-Centric Meta-Analysis of Lipid Traits in African, East Asian and Hispanic Populations.
PLoS One.
7.
2012
|
|
| 2012
|
Type 2 Diabetes Associated Changes in the Plasma Non-Esterified Fatty Acids, Oxylipins and Endocannabinoids.
PLoS One.
7.
2012
|
|
| 2012
|
Role of TRIB3 in regulation of insulin sensitivity and nutrient metabolism during short-term fasting and nutrient excess
2012
|
|
| 2012
|
American association of clinical endocrinologists' position statement on obesity and obesity medicine
2012
|
|
| 2012
|
Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction.
Metabolic Syndrome and Related Disorders.
10:244-251.
2012
|
|
| 2012
|
Adult mice maintained on a high-fat diet exhibit object location memory deficits and reduced hippocampal SIRT1 gene expression.
Neurobiology of Learning and Memory.
98:25-32.
2012
|
|
| 2012
|
Skeletal muscle lipid peroxidation and insulin resistance in humans.
Journal of Clinical Endocrinology and Metabolism.
97.
2012
|
|
| 2012
|
Noggin is novel inducer of mesenchymal stem cell adipogenesis: Implications for bone health and obesity.
Journal of Biological Chemistry.
287:12241-12249.
2012
|
|
| 2012
|
Adiponectin-AdipoR1/2-APPL1 signaling axis suppresses human foam cell formation: Differential ability of AdipoR1 and AdipoR2 to regulate inflammatory cytokine responses.
Atherosclerosis.
221:66-75.
2012
|
|
| 2012
|
Controlled-release phentermine/topiramate in severely obese adults: A randomized controlled trial (EQUIP).
Obesity.
20:330-342.
2012
|
|
| 2012
|
Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): A randomized, placebo-controlled, phase 3 extension study.
American Journal of Clinical Nutrition.
95:297-308.
2012
|
|
| 2012
|
Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus
2012
|
|
| 2011
|
A clustering analysis of lipoprotein diameters in the metabolic syndrome.
Lipids in Health and Disease.
10.
2011
|
|
| 2011
|
Significant Weight Loss With Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) Is Associated With Significant Reductions in Use of Concomitant Medications For Cardiometabolic Diseases Over 108 Weeks.
Obesity.
19:S176-S176.
2011
|
|
| 2011
|
Decreased progression to diabetes in subjects with prediabetes after 2 years of treatment with controlled-release phentermine/topiramate.
Diabetologia.
54:S371-S371.
2011
|
|
| 2011
|
Long-term weight loss with controlled-release phentermine/topiramate reverses metabolic syndrome and improves associated traits.
Diabetologia.
54:S370-S370.
2011
|
|
| 2011
|
Lipoprotein Lipase S447X variant associated with VLDL, LDL and HDL diameter clustering in the MetS.
Lipids in Health and Disease.
10.
2011
|
|
| 2011
|
Effects of macrophage-specific adiponectin expression on lipid metabolism in vivo
2011
|
|
| 2011
|
Intramyocellular lipid and insulin resistance: Differential relationships in European and African Americans.
Obesity.
19:1469-1475.
2011
|
|
| 2011
|
Dietary adherence during weight loss predicts weight regain.
Obesity.
19:1177-1181.
2011
|
|
| 2011
|
Genes and biochemical pathways in human skeletal muscle affecting resting energy expenditure and fuel partitioning.
Journal of Applied Physiology.
110:746-755.
2011
|
|
| 2010
|
Colesevelam in Combination with Metformin Significantly Reduces Low-Density Lipoprotein Particle Concentration in Patients with Early Type 2 Diabetes.
Circulation.
122.
2010
|
|
| 2010
|
Deletion of insulin receptor in chondrocytes sensitizes IGF-1 signaling and action.
Bone.
47:s446.
2010
|
|
| 2010
|
Low-Dose Controlled-Release Phentermine/Topiramate (PHEN/TPM CR) For Weight Loss and Management of Type 2 Diabetes Mellitus (T2DM).
Obesity.
18:S154-S155.
2010
|
|
| 2010
|
Colesevelam for Hispanic patients with hypercholesterolaemia and prediabetes.
Diabetologia.
53.
2010
|
|
| 2010
|
Initial treatment with metformin plus colesevelam provides greater glycaemic control than metformin alone in Hispanic patients with type 2 diabetes mellitus.
Diabetologia.
53.
2010
|
|
| 2010
|
Once-daily, low-dose, controlled-release phentermine/topiramate results in significant clinical improvements in overweight/obese patients with type 2 diabetes.
Diabetologia.
53.
2010
|
|
| 2010
|
Phentermine/topiramate combination therapy significantly improves glucose impairment in overweight/obese patients.
Diabetologia.
53.
2010
|
|
| 2010
|
Admixture Mapping of Type 2 Diabetes and Lipoprotein Subclasses in Gullah-Speaking African Americans in Project SuGAR.
Diabetes.
59:A337-A337.
2010
|
|
| 2010
|
Changes in Insulin Sensitivity in Overweight/Obese Patients Treated with Low-Dose, Controlled-Release Phentermine/Topiramate(PHEN/TPM).
Diabetes.
59:A481-A481.
2010
|
|
| 2010
|
Effects of Resistance Exercise and Aging on NR4A Protein Levels in Skeletal Muscle.
Diabetes.
59:A319-A320.
2010
|
|
| 2010
|
Improvements in Dyslipidemia and Other Cardiometabolic Disease Risk Factors with Low-Dose, Controlled-Release Phentermine/Topiramate (PHEN/TPM).
Diabetes.
59:A290-A291.
2010
|
|
| 2010
|
Initial Combination Therapy with Metformin plus Colesevelam Safely Achieves Glycemic and Lipid Goals with Less Diarrhea in Early Type 2 Diabetes Mellitus.
Diabetes.
59:A187-A187.
2010
|
|
| 2010
|
Lipid Metabolism Modulated by Macrophage Adiponectin Expression In Vivo.
Diabetes.
59:A433-A433.
2010
|
|
| 2010
|
Metabolic Effects of Adipocyte-Specific NR4A3 Over-Expression in Mice.
Diabetes.
59:A394-A394.
2010
|
|
| 2010
|
Once-Daily, Low-Dose, Controlled-Release Phentermine/Topiramate Demonstrates Significant Improvement in Weight, Related Risk in Overweight/Obese Patients with Comorbidities..
Endocrine Reviews.
31.
2010
|
|
| 2010
|
Osteocalcin Effects on Cytokine Secretion by Adipose Tissue and Glucose Uptake in L6 Muscle Cells: Linking the Skeleton with Insulin Resistance and Inflammation.
Diabetes.
59:A395-A395.
2010
|
|
| 2010
|
The Safety and Tolerability of Metformin plus Colesevelam in Drug-Naive Patients with Early Type 2 Diabetes Mellitus.
Diabetes.
59:A173-A173.
2010
|
|
| 2010
|
Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis.
Diabetes.
59:791-799.
2010
|
|
| 2010
|
Skeletal muscle HNE is related to insulin resistance in sedentary individuals
2010
|
|
| 2010
|
Type 2 Diabetes-associated changes in the plasma lipidome in obese women
2010
|
|
| 2010
|
Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: Role in glucose-induced insulin resistance
2010
|
|
| 2010
|
The genetic architecture of lipoprotein subclasses in Gullah-speaking African American families enriched for type 2 diabetes: The Sea Islands Genetic African American Registry (Project SuGAR).
Journal of Lipid Research.
51:586-597.
2010
|
|
| 2010
|
A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes..
Diabetes Technology and Therapeutics.
12:419-425.
2010
|
|
| 2010
|
Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
2010
|
|
| 2010
|
Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
2010
|
|
| 2010
|
Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women.
PLoS One.
5:1-10.
2010
|
|
| 2010
|
Relationship between Insulin Sensitivity and Muscle Lipids may Differ with Muscle Group and Ethnicity.
2010
|
|
| 2009
|
Adipose tissue exosome-like vesicles mediate activation of macrophage-induced insulin resistance.
Diabetes.
58:2498-2505.
2009
|
|
| 2009
|
One-Year Treatment with Low Dose VI-0521 in Type 2 Diabetes Demonstrates Sustained Weight Loss and Continuous Glycemic Benefit.
Obesity.
17:S52-S52.
2009
|
|
| 2009
|
The Plasma Metabolome in Overweight Type 2 Diabetes Mellitus (T2DM) vs. Non-Diabetic Subjects with or without an Uncoupling Protein 3 (UCP3) Missense Mutation Reveals Novel Metabolite Signatures Reflective of Genotype and Diabetic Status.
Obesity.
17:S176-S176.
2009
|
|
| 2009
|
A qualitative assessment of educational opportunities for primary care providers in type 2 diabetes care.
Diabetes Spectrum.
22:248-253.
2009
|
|
| 2009
|
Treatment with VI-0521 (phentermine and topiramate) leads to one year durable glycaemic benefit and weight loss in subjects with type 2 diabetes.
Diabetologia.
52:S77-S77.
2009
|
|
| 2009
|
Helicobacter pylori Infection and Inflammation: Implication for the Pathophysiology of Diabetes and Coronary Heart Disease in Asian Indians..
Journal of life science.
1:45-50.
2009
|
|
| 2009
|
Apolipoprotein-Defined Lipoproteins in the DCCT/EDIC Cohort: Associations with Diabetic Nephropathy in Type 1 Diabetes.
Diabetes.
58:A243-A243.
2009
|
|
| 2009
|
Genes and Biochemical Pathways in Human Skeletal Muscle Affecting Resting Energy Expenditure and Fuel Partitioning.
Diabetes.
58:A362-A362.
2009
|
|
| 2009
|
One-Year Treatment with VI-0521 in Type 2 Diabetes Demonstrates Continued Glycemic Improvement and Weight Loss.
Diabetes.
58:A95-A95.
2009
|
|
| 2009
|
Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid β-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women
2009
|
|
| 2009
|
H. pylori-induced higher C-reactive protein in obese African Americans.
Artery Research.
3:39-42.
2009
|
|
| 2009
|
Adiponectin reduces lipid accumulation in macrophage foam cells.
Atherosclerosis.
202:152-161.
2009
|
|
| 2009
|
Genome-wide linkage scan in gullah-speaking african american families with type 2 diabetes: The sea islands genetic African American Registry (Project SuGAR).
Diabetes.
58:260-267.
2009
|
|
| 2009
|
NUTRITION AND CONTROL OF DIABETES IN HOSPITALIZED PATIENTS
2009
|
|
| 2008
|
Adiponectin multimers and metabolic syndrome traits: Relative adiponectin resistance in African Americans.
Obesity.
16:2616-2623.
2008
|
|
| 2008
|
Intracellular Lipid Accumulation in Liver and Muscle and the Insulin Resistance Syndrome.
Endocrinology and Metabolism Clinics of North America.
37:841-856.
2008
|
|
| 2008
|
Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial.
JAMA Ophthalmology.
126:1707-1715.
2008
|
|
| 2008
|
Entero-insular axis and postprandial insulin differences in African American and European American children.
American Journal of Clinical Nutrition.
88:1277-1283.
2008
|
|
| 2008
|
Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes.
Nutrition.
24:990-997.
2008
|
|
| 2008
|
PIOGLITAZONE PREVENTS OBESITY-INDUCED MITOCHONDRIAL DYSFUNCTION IN LIVER OF THE DIABETIC ZUCKER FATTY RAT.
Hepatology.
48:830A-830A.
2008
|
|
| 2008
|
Risk factors related to inflammation and endothelial dysfunction in the dcct/edic cohort and their relationship with nephropathy and macrovascular complications.
Diabetes reviews (Alexandria, Va.).
31:2006-2012.
2008
|
|
| 2008
|
The Weight Effects of VI-0521 in Type 2 Diabetes.
Obesity.
16:S294-S294.
2008
|
|
| 2008
|
Effect of VI-0521 (phentermine and topiramate) in type 2 diabetes.
Diabetes.
57:A112-A112.
2008
|
|
| 2008
|
Genome-wide linkage scan in Gullah-speaking African American families with Type 2 diabetes: The Sea Islands Genetic African American Registry (Project SuGAR).
Diabetes.
57:A321-A321.
2008
|
|
| 2008
|
Metabolic syndrome traits and endothelial dysfunction: Role of ethnicity.
Diabetes.
57:A620-A620.
2008
|
|
| 2008
|
Osteocalcin is not just for bones: Effects on adipocytes and role in human metabolism.
Diabetes.
57:A29-A29.
2008
|
|
| 2008
|
Overexpression of adiponectin reduces lipid accumulation in human THP-1 macrophage foam cells.
Diabetes.
57:A631-A631.
2008
|
|
| 2008
|
The HOMA index estimation of insulin resistance is affected by ethnicity.
Diabetes.
57:A292-A292.
2008
|
|
| 2008
|
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.
Journal of Diabetes and Its Complications.
22:153-163.
2008
|
|
| 2008
|
Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort.
Journal of Diabetes and Its Complications.
22:153-163.
2008
|
|
| 2008
|
Comprehensive plasma acylcarnitine profiles of type 2 diabetic and non-diabetic subjects with or without an uncoupling protein 3 (UCP3) missense polymorphism
2008
|
|
| 2008
|
Diagnosis and management of prediabetes in the continuum of hyperglycemia - When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists
2008
|
|
| 2008
|
Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects
2008
|
|
| 2008
|
Ethnic heterogeneity in glucoregulatory function during treatment with atypical antipsychotics in patients with schizophrenia.
Journal of Psychiatric Research.
42:1076-1085.
2008
|
|
| 2007
|
Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.
Journal of the American Society of Hypertension.
1:414-422.
2007
|
|
| 2007
|
Reply: 'Second generation antipsychotic drugs: Is there a common mechanism in the development of obesity?' [2].
Neuropsychopharmacology.
32:2433-2434.
2007
|
|
| 2007
|
NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: Potential role in insulin resistance.
Journal of Biological Chemistry.
282:31525-31533.
2007
|
|
| 2007
|
Adiponectin and the metabolic syndrome: Mechanisms mediating risk for metabolic and cardiovascular disease.
Current Opinion in Lipidology.
18:263-270.
2007
|
|
| 2007
|
Ethnic differences in adiponectin multimer distribution and relationships with metabolic syndrome traits.
Diabetes.
56:A361-A361.
2007
|
|
| 2007
|
Fat depots and adipokines in morbidly obese individuals.
Diabetes.
56:A464-A464.
2007
|
|
| 2007
|
Functional study of Trb 3 related to diabetic skeletal muscle.
Diabetes.
56:A346-A346.
2007
|
|
| 2007
|
Pioglitazone therapy restores the coupling of electron transport to ATP synthesis in skeletal muscle of obese zucker rats.
Diabetes.
56:A85-A86.
2007
|
|
| 2007
|
Long-term effect of diabetes and its treatment on cognitive function..
New England Journal of Medicine.
356:1842-1852.
2007
|
|
| 2007
|
Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis.
Neuropsychopharmacology.
32:765-772.
2007
|
|
| 2007
|
Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina.
Health and Place.
13:179-187.
2007
|
|
| 2007
|
The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle.
Endocrine.
31:5-17.
2007
|
|
| 2007
|
The effect of insulin on expression of genes and biochemical pathways in human skeletal muscle (Endocrine (2007) 31, 1 (5-17) DOI: 10.1007/s12020-007- 0007-x).
Endocrine.
32:356.
2007
|
|
| 2006
|
Polymorphism in the transcription factor 7-Like 2 (TCF7L2) gene is associated with reduced insulin secretion in nondiabetic women.
Diabetes.
55:3630-3634.
2006
|
|
| 2006
|
Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques.
Journal of Cardiovascular Pharmacology.
48:212-222.
2006
|
|
| 2006
|
Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages.
Atherosclerosis.
188:102-111.
2006
|
|
| 2006
|
Nuclear magnetic resonance-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Associations with carotid intima-media thickness.
Diabetic Medicine.
23:955-966.
2006
|
|
| 2006
|
Proinflammatory cytokine production and insulin sensitivity regulated by overexpression of resistin in 3T3-L1 adipocytes.
Nutrition and Metabolism.
3.
2006
|
|
| 2006
|
A diabetes management program using diabetes-specific meal replacements and snack bars improves weight loss, metabolic parameters, and quality of life (QOL).
Diabetes.
55:A596-A596.
2006
|
|
| 2006
|
A role for C/EBP-delta in mitochondrial dysfunction and insulin resistance in skeletal muscle.
Diabetes.
55:A304-A304.
2006
|
|
| 2006
|
CETP gene variation has pronounced independent effect on HDL levels and HDL particle size in type 1 diabetes.
Diabetes.
55:A252-A252.
2006
|
|
| 2006
|
Effects of short-term very low calorie diet (VLCD) on secretion of adipocytokines in human adipose tissue.
Diabetes.
55:A313-A313.
2006
|
|
| 2006
|
Resistin autoregulates inflammatory cytokine production and induces insulin resistance in adipocytes.
Diabetes.
55:A310-A310.
2006
|
|
| 2006
|
Editorial: Uncoupling protein 3 and human metabolism.
Journal of Clinical Endocrinology and Metabolism.
91:1226-1228.
2006
|
|
| 2006
|
Molecular characterization of human melanocortin-3 receptor ligand-receptor interaction.
Biochemistry.
45:1128-1137.
2006
|
|
| 2006
|
Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
Diabetes.
55:249-259.
2006
|
|
| 2005
|
Adiponectin promotes adipocyte differentiation, insulin sensitivity, and lipid accumulation.
Journal of Lipid Research.
46:1369-1379.
2005
|
|
| 2005
|
Modified lipoprotein-immune complexes and progression of internal carotid intima-media thickness in type 1 diabetes.
Circulation.
112:U848-U849.
2005
|
|
| 2005
|
Mitochondrial DNA genetic diversity among four ethnic groups in Sierra Leone.
American Journal of Physical Anthropology.
128:156-163.
2005
|
|
| 2005
|
Mitochondrial DNA (mtDNA) haplotypes reveal maternal population genetic affinities of Sea Island Gullah-speaking African Americans.
American Journal of Physical Anthropology.
127:427-438.
2005
|
|
| 2005
|
Adiponectin multimeric complexes and the metabolic syndrome trait cluster.
Diabetes.
54:A347-A348.
2005
|
|
| 2005
|
Administration of pioglitazone to LDL receptor-deficient mice inhibits progression of intimal lesions and expression of matrix metalloproteinases and adhesion molecules.
Diabetes.
54:A182-A182.
2005
|
|
| 2005
|
Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: Associations with microvascular disease complications in the DCCT/EDIC cohort.
Journal of Diabetes and Its Complications.
19:18-25.
2005
|
|
| 2005
|
Dysregulation of mitochondria-related genes in skeletal muscle from insulin resistant humans is associated with suppression of transcription factors involved in mitochondrial biogenesis.
Diabetes.
54:A273-A273.
2005
|
|
| 2005
|
Lipid metabolism mediated by adipocyte lipid binding protein (ALBP/aP2) gene expression in human THP-1 macrophages.
Diabetes.
54:A188-A188.
2005
|
|
| 2005
|
Proteomics analysis of skeletal muscle mitochondria in type 2 diabetes reveals altered concentrations and oxidation of respiratory chain proteins.
Diabetes.
54:A58-A59.
2005
|
|
| 2004
|
Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: Associations with lipoprotein subclasses
2004
|
|
| 2004
|
Chronic alcohol consumption induces the metabolic stress chaperone prohibitin in liver mitochondria..
Hepatology.
40:711A-711A.
2004
|
|
| 2004
|
Diet, insulin resistance, and obesity: Zoning in on data for Atkins dieters living in South Beach.
Journal of Clinical Endocrinology and Metabolism.
89:4197-4205.
2004
|
|
| 2004
|
Associations of adiponectin with retinopathy in the DCCT/EDIC cohort: Influence of insulin resistance.
Diabetes.
53:A254-A254.
2004
|
|
| 2004
|
Effects of atypical antipsychotic drugs on insulin action in adipocytes.
Diabetes.
53:A150-A150.
2004
|
|
| 2004
|
Estimation of resting energy expenditure considering effects of race and diabetes status.
Diabetes reviews (Alexandria, Va.).
27:1405-1411.
2004
|
|
| 2004
|
Overexpression of adiponectin but not resistin enhances adipocyte differentiation and insulin sensitivity.
Diabetes.
53:A79-A79.
2004
|
|
| 2004
|
Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance with Dyslipidemia.
Diabetes reviews (Alexandria, Va.).
27:978-983.
2004
|
|
| 2004
|
Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort
2004
|
|
| 2004
|
Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: A role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation.
Blood Cells, Molecules and Diseases.
32:182-190.
2004
|
|
| 2004
|
Foreword from the editors.
Nutrition.
20:1.
2004
|
|
| 2004
|
Individual differences in the response to ingested nutrients..
Nutrition.
20:1.
2004
|
|
| 2004
|
Proteomic analysis of skeletal muscle mitochondria reveal decreases in complex I and IV of the electron transport chain.
Free Radical Biology and Medicine.
37:S27-S27.
2004
|
|
| 2004
|
Role of UCP2 and UCP3 in nutrition and obesity.
Nutrition.
20:139-144.
2004
|
|
| 2003
|
Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy - The Epidemiology of Diabetes Interventions and Complications (EDIC) study.
Journal of the American Medical Association.
290:2159-2167.
2003
|
|
| 2003
|
Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy.
Kidney International.
64:817-828.
2003
|
|
| 2003
|
Lipoprotein abnormalities in type 1 diabetes.
Current Opinion in Endocrinology, Diabetes and Obesity.
10:245-250.
2003
|
|
| 2003
|
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus..
New England Journal of Medicine.
348:2294-2303.
2003
|
|
| 2003
|
Alterations in skeletal muscle caveolins 1 and 3 in human insulin resistance and obesity.
Diabetes.
52:A330-A331.
2003
|
|
| 2003
|
Relationship between insulin senstivity and intramyocellular lipid during short term very low calorie diet in obese type 2 diabetics.
Diabetes.
52:A328-A328.
2003
|
|
| 2003
|
Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.
Diabetes reviews (Alexandria, Va.).
26:1439-1448.
2003
|
|
| 2003
|
Plasma prekallikrein: A risk marker for hypertension and nephropathy in type 1 diabetes.
Diabetes.
52:1215-1221.
2003
|
|
| 2003
|
Serum lipoproteins in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications cohort: Associations with gender and glycemia.
Diabetes reviews (Alexandria, Va.).
26:810-818.
2003
|
|
| 2003
|
The role of uncoupling protein 3 in human physiology.
Journal of Clinical Investigation.
111:438-441.
2003
|
|
| 2003
|
Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
Diabetes.
52:453-462.
2003
|
|
| 2003
|
The role of uncoupling protein 3 in human physiology..
Journal of Clinical Investigation.
111:438-441.
2003
|
|
| 2003
|
The role of uncoupling protein 3 in human physiology.
Journal of Clinical Investigation.
111:438-441.
2003
|
|
| 2003
|
Three novel mtDNA restriction site polymorphisms allow exploration of population affinities of African Americans
2003
|
|
| 2002
|
The adipocyte lipid binding protein (ALBP/aP2) gene facilitates foam cell formation in human THP-1 macrophages.
Atherosclerosis.
165:259-269.
2002
|
|
| 2002
|
Effective use of thiazolidinediones for the treatment of glucocorticoid-induced diabetes.
Diabetes Research and Clinical Practice.
58:87-96.
2002
|
|
| 2002
|
Troglitazone antagonizes metabolic effects of glucocorticoids in humans: Effects on glucose tolerance, insulin sensitivity, suppression of free fatty acids, and leptin.
Diabetes.
51:2895-2902.
2002
|
|
| 2002
|
Connective tissue growth factor (CTGF) N fragment: A marker for progressive diabetic nephropathy..
Journal of the American Society of Nephrology.
13:249A-249A.
2002
|
|
| 2002
|
Flotillin-1 expression in skeletal muscle is altered in insulin resistant humans.
Diabetes.
51:A302-A302.
2002
|
|
| 2002
|
Hepatic lipase gene polymorphism is a major determinant of HDL level and HDL size in men with type 1 diabetes in the DCCT/EDIC.
Diabetes.
51:A20-A20.
2002
|
|
| 2001
|
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: implications regarding defects in vesicle trafficking..
Journal of Clinical Endocrinology and Metabolism.
86:5450-5456.
2001
|
|
| 2001
|
Microarray analysis of changes in skeletal muscle gene expression in response to insulin..
American Journal of Human Genetics.
69:451-451.
2001
|
|
| 2001
|
Mitochondrial DNA and Y-chromosome haplotypes of Gullah-speaking African Americans show closer genetic distance to Sierra Leoneans and lower Caucasian admixture than other new world African populations..
American Journal of Human Genetics.
69:227-227.
2001
|
|
| 2001
|
A role for the Agouti-Related Protein promoter in obesity and type 2 diabetes.
Biochemical and Biophysical Research Communications.
287:568-573.
2001
|
|
| 2001
|
Effects of Insulin Resistance and type 2 diabetes on the nuclear magnetic resonance lipoprotein subclass profile.
Diabetes.
50:A147-A147.
2001
|
|
| 2001
|
Effects of race on the NMR lipoprotein profile and insulin resistance syndrome: Lipids and blood pressure are not influenced by insulin resistance in African Americans.
Diabetes.
50:A306-A306.
2001
|
|
| 2001
|
Postprandial glucose and insulin responses to dextrin-containing medical nutritional bars in persons with type 2 diabetes mellitus.
Diabetes.
50:A366-A366.
2001
|
|
| 2001
|
SNARE proteins (Syntaxin4, VAMP2, munc18) and skeletal muscle insulin resistance in rats and humans.
Diabetes.
50:A270-A270.
2001
|
|
| 2001
|
Ancestral proportions and admixture dynamics in geographically defined African Americans living in South Carolina.
American Journal of Physical Anthropology.
114:18-29.
2001
|
|
| 2001
|
Adipocytes exhibit abnormal subcellular distribution and translocation of vesicles containing glucose transporter 4 and insulin-regulated aminopeptidase in type 2 diabetes mellitus: Implications regarding defects in vesicle trafficking.
Journal of Clinical Endocrinology and Metabolism.
86:5450-5456.
2001
|
|
| 2001
|
Beneficial effects of intensive therapy of diabetes during adolescence: Outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).
Journal of Pediatrics.
139:804-812.
2001
|
|
| 2000
|
Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans
2000
|
|
| 2000
|
Reduced plasma leptin concentrations in bulimia nervosa.
Psychoneuroendocrinology.
25:649-658.
2000
|
|
| 2000
|
Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Associations with retinopathy and nephropathy.
Diabetes.
49:A269-A269.
2000
|
|
| 2000
|
Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile in the DCCT/EDIC cohort: Effects of gender, HbAlc, and DCCT randomization group..
Diabetes.
49:A267-A267.
2000
|
|
| 2000
|
Nuclear magnetic resonance (NMR)-determined lipoprotein subclass profile: Effects of hyperglycemia, lipoprotein glycation, and comparison with standard lipid profile.
Diabetes.
49:A268-A268.
2000
|
|
| 2000
|
Paraoxonase genotype (192 Gln-Arg) and serum paraoxonase-arylesterase activity: Relationship with Type 1 diabetes and nephropathy.
Diabetes.
49:A157-A157.
2000
|
|
| 2000
|
Troglitazone is an effective therapeutic agent in patients with steroid-induced diabetes.
Diabetes.
49:A129-A129.
2000
|
|
| 2000
|
High-resolution admixture map of African Americans living in South Carolina..
American Journal of Physical Anthropology.
245-246.
2000
|
|
| 1999
|
Endogenous mutations in human uncoupling protein 3 alter its functional properties.
FEBS Letters.
464:189-193.
1999
|
|
| 1999
|
Role of human mitochondrial translocators in the import of nuclear encoded proteins..
American Journal of Human Genetics.
65:A182-A182.
1999
|
|
| 1999
|
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome.
Diabetes reviews (Alexandria, Va.).
22:1310-1317.
1999
|
|
| 1999
|
Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione..
Endocrinology.
140:1151-1157.
1999
|
|
| 1999
|
Aberrant DNA sequence pattern caused by a heterozygosity
1999
|
|
| 1999
|
Hyperfibrinogenemia is associated with nephropathy in type 1 diabetes.
Diabetes.
48:A139-A139.
1999
|
|
| 1999
|
Low birth weight is associated with reduced expression of GLUT4 and carnitine palmitoyltransferase-1 in adult skeletal muscle.
Diabetes.
48:A274-A275.
1999
|
|
| 1999
|
Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: Decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione
1999
|
|
| 1999
|
Plasminogen activator inhibitor-1 is increased in type 1 diabetes patients with hypertension.
Diabetes.
48:A43-A43.
1999
|
|
| 1999
|
Sickle cell haplotypes of the African American "Gullah" of the South Carolina Sea Islands..
American Journal of Physical Anthropology.
233-234.
1999
|
|
| 1999
|
Toward rational diagnostic criteria for the insulin resistance syndrome.
Diabetes.
48:A29-A29.
1999
|
|
| 1999
|
Troglitazone prevents glucocorticoid-induced insulin resistance in humans.
Diabetes.
48:A75-A75.
1999
|
|
| 1998
|
Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes.
Journal of Clinical Investigation.
102:1345-1351.
1998
|
|
| 1998
|
Insulin action and insulin resistance: Diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system.
American Journal of Medicine.
105:331-345.
1998
|
|
| 1998
|
Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: Structure-function relationships and studies in a compound heterozygous proband.
Journal of Lipid Research.
39:1870-1876.
1998
|
|
| 1998
|
Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.
Journal of Clinical Investigation.
101:2377-2386.
1998
|
|
| 1998
|
Apolipoprotein CIII polymorphism confers altered chemical composition of triglyceride-rich lipoprotein in type 1 diabetes.
Diabetes.
47:A32-A32.
1998
|
|
| 1998
|
Insulin resistance and defective glucose-insulin coupling in ketosis-prone type 2 diabetes of African-American youth.
Diabetes.
47:A306-A306.
1998
|
|
| 1998
|
The role of uncoupling proteins in metabolic fuel partitioning and human obesity.
Diabetes.
47:A13-A13.
1998
|
|
| 1998
|
Structure and organization of the human uncoupling protein 2 gene and identification of a common biallelic variant in Caucasian and African- American subjects.
Diabetes.
47:685-687.
1998
|
|
| 1998
|
An autosomal genomic scan for loci linked to prediabetic phenotypes in pima indians.
Journal of Clinical Investigation.
101:1757-1764.
1998
|
|
| 1998
|
An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians.
American Journal of Human Genetics.
63:1130-1138.
1998
|
|
| 1998
|
Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians.
American Journal of Human Genetics.
62:659-668.
1998
|
|
| 1998
|
Clinical implications of the insulin resistance syndrome.
Clinical Cornerstone.
1:13-26.
1998
|
|
| 1998
|
Cloning of Rab GTPases expressed in human skeletal muscle: Studies in insulin-resistant subjects.
Hormone and Metabolic Research.
30:656-662.
1998
|
|
| 1998
|
Diabetes research in South Carolina: past, present, and future..
Journal of the South Carolina Medical Association (1975).
94:502-508.
1998
|
|
| 1998
|
Expression of mRNAs encoding uncoupling proteins in human skeletal muscle. Effects of obesity and diabetes.
Diabetes.
47:1935-1940.
1998
|
|
| 1997
|
Identification of Rad's effector-binding domain, intracellular localization, and analysis of expression in Pima Indians.
Journal of Cellular Biochemistry.
65:527-541.
1997
|
|
| 1997
|
Genome scan for linkage to pre-diabetic traits in Pima Indians.
Diabetologia.
40:615-615.
1997
|
|
| 1997
|
Gestational diabetes mellitus and gene mutations which affect insulin secretion.
Diabetes Research and Clinical Practice.
36:135-141.
1997
|
|
| 1997
|
Decreased insulin-stimulated Z-deoxyglucose uptake and impaired GLUT4 translocation in skeletal muscle of transgenic mice overexpressing glutamine: Fructose-6-phosphate amidotransferase..
Diabetes.
46:259-259.
1997
|
|
| 1997
|
Ketosis-prone NIDDM in African-American children..
Diabetes.
46:262-262.
1997
|
|
| 1997
|
NIDDM and obesity are associated with Protein Kinase C abnormalities in human skeletal muscle.
Diabetes.
46:87-87.
1997
|
|
| 1997
|
The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure.
Journal of Clinical Endocrinology and Metabolism.
82:1293-1300.
1997
|
|
| 1997
|
Multiple endocrinopathies in an infant with fatal neurodegenerative disease.
American Journal of Medical Genetics Part A.
69:271-279.
1997
|
|
| 1997
|
The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure..
Journal of Clinical Endocrinology and Metabolism.
82:1293-1300.
1997
|
|
| 1997
|
Exercise in transgenic mice overexpressing GLUT4 glucose transporters: Effects on substrate metabolism and glycogen regulation
1997
|
|
| 1997
|
Genomewide search for genes influencing percent body fat in Pima Indians: Suggestive linkage at chromosome 11q21-q22.
American Journal of Human Genetics.
60:166-173.
1997
|
|
| 1997
|
Muscle rad expression and human metabolism: Potential role of the novel ras-related GTPase in energy expenditure and body composition.
Diabetes.
46:444-450.
1997
|
|
| 1996
|
Identification of Rad's effector-binding domain, intracellular localization and analysis of expression in Pima Indians..
Molecular Biology of the Cell.
7:3060-3060.
1996
|
|
| 1996
|
Isolation by preparative free-flow electrophoresis and aqueous two-phase partition from rat adipocytes of an insulin-responsive small vesicle fraction with glucose transport activity
1996
|
|
| 1996
|
Correlation of leptin and body fat in obese, lean, and lipodystrophic humans..
Diabetes.
45:1229-1229.
1996
|
|
| 1996
|
Dual energy X-ray absorptiometry (DXA) assessment of fat mass and distribution and its association with the insulin resistance syndrome (IRS)..
Diabetes.
45:387-387.
1996
|
|
| 1996
|
Fat and muscle tissue express a common abnormality in translocation/trafficking of GLUT4/vp165 containing vesicles in NIDDM..
Diabetes.
45:573-573.
1996
|
|
| 1996
|
The metabolic significance of leptin in humans..
Diabetes.
45:940-940.
1996
|
|
| 1996
|
The expression of TNFα by human muscle: Relationship to insulin resistance.
Journal of Clinical Investigation.
97:1111-1116.
1996
|
|
| 1995
|
The effects of brefeldin A on the glucose transport system in rat adipocytes: Implications regarding the intracellular locus of insulin-sensitive Glut4.
Journal of Biological Chemistry.
270:30199-30204.
1995
|
|
| 1995
|
CHARACTERIZATION OF RAD ANTIBODY EPITOPES, GTP-BINDING PROPERTIES, AND EXPRESSION IN SKELETAL-MUSCLE OF TYPE-II DIABETICS AND THE ZUCKER DIABETIC FATTY RAT.
Molecular Biology of the Cell.
6:2042-2042.
1995
|
|
| 1995
|
Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: effects on blood flow and differential expression of GLUT 4 in skeletal muscles..
Journal of Clinical Endocrinology and Metabolism.
80:2437-2446.
1995
|
|
| 1995
|
ABNORMALITIES IN GLUT-4 TRANSLOCATION AND TRAFFICKING IN SKELETAL-MUSCLE CAUSE INSULIN-RESISTANCE IN HUMANS.
Diabetes.
44:A164-A164.
1995
|
|
| 1995
|
GLUCOSAMINE (GLMN) INDUCES INSULIN-RESISTANCE (IR) IN-VIVO BY AFFECTING GLUT 4 TRANSLOCATION IN SKELETAL-MUSCLE - IMPLICATIONS FOR GLUCOSE TOXICITY.
Diabetes.
44:A15-A15.
1995
|
|
| 1995
|
RAD EXPRESSION IN SKELETAL-MUSCLE OF TYPE-II DIABETICS.
Diabetes.
44:A186-A186.
1995
|
|
| 1995
|
Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle: Implications for glucose toxicity.
Journal of Clinical Investigation.
96:2792-2801.
1995
|
|
| 1995
|
Mechanisms of enhanced insulin sensitivity in endurance-trained athletes: Effects on blood flow and differential expression of GLUT 4 in skeletal muscles.
Journal of Clinical Endocrinology and Metabolism.
80:2437-2446.
1995
|
|
| 1994
|
Gene expression of epithelial glucose transporters: The role of diabetes mellitus.
Journal of the American Society of Nephrology.
5.
1994
|
|
| 1994
|
Gene expression of epithelial glucose transporters: the role of diabetes mellitus..
Journal of the American Society of Nephrology.
5:S29-S36.
1994
|
|
| 1994
|
Gene expression of epithelial glucose transporters: the role of diabetes mellitus..
Journal of the American Society of Nephrology.
5:s29.
1994
|
|
| 1994
|
MUSCLE GLUT 4 EXPRESSION IS A FAMILIAL TRAIT AND DETERMINES INSULIN SENSITIVITY IN HUMANS INDEPENDENT OF OBESITY.
Diabetes.
43:A69-A69.
1994
|
|
| 1994
|
THE GOLGI-APPARATUS IS NOT REQUIRED FOR INSULIN STIMULATION OF GLUCOSE-TRANSPORT AND GLUT-4 TRANSLOCATION IN RAT ADIPOCYTES.
Diabetes.
43:A119-A119.
1994
|
|
| 1994
|
Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats.
American Journal of Physiology.
266:f283-f290.
1994
|
|
| 1994
|
Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats..
American Journal of Physiology.
266:F283-F290.
1994
|
|
| 1994
|
Biological actions of insulin are differentially regulated by glucose and insulin in primary cultured adipocytes: Chronic ability to increase glycogen synthase activity.
Diabetes.
43:53-62.
1994
|
|
| 1994
|
Glucose transporter proteins and insulin sensitivity in humans..
Brazilian Journal of Medical and Biological Research.
27:933-939.
1994
|
|
| 1994
|
Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats.
American Journal of Physiology.
266.
1994
|
|
| 1993
|
Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes. Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.
Diabetes.
42:1773-1785.
1993
|
|
| 1993
|
Potential role for insulin and cycloheximide in regulating the intrinsic activity of glucose transporters in isolated rat adipocytes..
Endocrinology.
133:2943-2950.
1993
|
|
| 1993
|
Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles..
Journal of Clinical Endocrinology and Metabolism.
77:286-289.
1993
|
|
| 1993
|
MECHANISMS UNDERLYING PERIPHERAL-NERVE GLUCOSE-UPTAKE SUPPRESSION IN DIABETES.
Diabetes.
42:A102-A102.
1993
|
|
| 1993
|
Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy.
American Journal of Physiology.
264:h837-h844.
1993
|
|
| 1993
|
Effects of diabetes on myocardial glucose transport system in rats: implications for diabetic cardiomyopathy..
American Journal of Physiology.
264:H837-H844.
1993
|
|
| 1993
|
1 Cellular insulin action and insulin resistance
1993
|
|
| 1993
|
Effects of diabetes on myocardial glucose transport system in rats: Implications for diabetic cardiomyopathy.
American Journal of Physiology.
264.
1993
|
|
| 1993
|
Insulin-responsive human adipocytes express two glucose transporter isoforms and target them to different vesicles.
Journal of Clinical Endocrinology and Metabolism.
77:286-289.
1993
|
|
| 1993
|
Multiple defects in the adipocyte glucose transport system cause cellular insulin resistance in gestational diabetes: Heterogeneity in the number and a novel abnormality in subcellular localization of GLUT4 glucose transporters.
Diabetes.
42:1773-1785.
1993
|
|
| 1993
|
Muscle group-specific regulation of GLUT 4 glucose transporters in control, diabetic, and insulin-treated diabetic rats
1993
|
|
| 1993
|
Potential role for insulin and cycloheximide in regulating the intrinsic activity of glucose transporters in isolated rat adipocytes
1993
|
|
| 1992
|
MECHANISMS OF ENHANCED INSULIN ACTION IN ENDURANCE-TRAINED ATHLETES.
Clinical research.
40:A733-A733.
1992
|
|
| 1992
|
Glucose transporters of rat proximal tubule: differential expression and subcellular distribution.
American Journal of Physiology.
262:f807-f812.
1992
|
|
| 1992
|
Glucose transporters of rat proximal tubule: differential expression and subcellular distribution..
American Journal of Physiology.
262:F807-F812.
1992
|
|
| 1992
|
DIABETES DEPRESSES THE RAT CARDIAC NA+/CA2+ EXCHANGER.
Clinical research.
40:A257-A257.
1992
|
|
| 1992
|
Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
Diabetes.
41:465-475.
1992
|
|
| 1992
|
Glucose and insulin chronically regulate insulin action via different mechanisms in BC3H1 myocytes: Effects on glucose transporter gene expression.
Diabetes.
41:274-285.
1992
|
|
| 1992
|
Glucose transport and NIDDM.
Diabetes reviews (Alexandria, Va.).
15:396-417.
1992
|
|
| 1992
|
Glucose transporters of rat proximal tubule: Differential expression and subcellular distribution.
American Journal of Physiology.
262.
1992
|
|
| 1991
|
Demonstration of a 1,25-dihydroxyvitamin D3-responsive protein in human lymphocytes: Immunologic crossreactivity and inverse regulation with the vitamin D receptor
1991
|
|
| 1991
|
Glucose and insulin regulate insulin sensitivity in primary cultured adipocytes without affecting insulin receptor kinase activity
1991
|
|
| 1991
|
ADAPTATIONS OF THE RAT RENAL PROXIMAL TUBULE TO UNCONTROLLED DIABETES.
Clinical research.
39:A307-A307.
1991
|
|
| 1991
|
EXPRESSION OF GLUT4 VARIES AS A FUNCTION OF SKELETAL-MUSCLE GROUP IN CONTROL, DIABETIC, AND INSULIN-TREATED DIABETIC RATS.
Pediatric Research.
29:A78-A78.
1991
|
|
| 1991
|
REGULATION OF TISSUE GLUT4 CONTENT VARIES AS A FUNCTION OF SKELETAL-MUSCLE GROUP AND CANNOT TOTALLY EXPLAIN INSULIN RESISTANCE IN DIABETIC RATS.
Clinical research.
39:A354-A354.
1991
|
|
| 1991
|
New insights into the metabolic regulation of insulin action and insulin resistance: Role of glucose and amino acids
1991
|
|
| 1991
|
Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
Journal of Clinical Investigation.
87:1072-1081.
1991
|
|
| 1989
|
Dexamethasone regulates the glucose transport system in primary cultured adipocytes: Different mechanisms of insulin resistance after acute and chronic exposure
1989
|
|
| 1989
|
Expression of a glucose transporter gene cloned from brain in cellular models of insulin resistance: Dexamethasone decreases transporter mRNA in primary cultured adipocytes
1989
|
|
| 1989
|
Glucose transport in primary cultured neurons.
Journal of Neuroscience Research.
22:397-407.
1989
|
|
| 1989
|
Insulin resistance and noninsulin‐dependent diabetes mellitus: Which horse is pulling the cart?
1989
|
|
| 1989
|
Pretranslational suppression of an insulin-responsive glucose transporter in rats with diabetes mellitus.
Science.
245:60-63.
1989
|
|
| 1989
|
Y-1 adrenocortical tumor cells contain atrial natriuretic peptide receptors which regulate cyclic nucleotide metabolism and steroidogenesis
1989
|
|
| 1988
|
Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes.
American Journal of Medicine.
85:86-105.
1988
|
|
| 1988
|
Cellular mechanisms of insulin resistance in non-insulin-dependent (type II) diabetes..
American Journal of Medicine.
85:86-105.
1988
|
|
| 1988
|
Correlation of in vivo and in vitro actions of insulin in obesity and noninsulin-dependent diabetes mellitus: Role of the glucose transport system
1988
|
|
| 1988
|
Day-long integrated serum insulin and C-peptide profiles in patients with NIDDM. Correlation with urinary C-peptide excretion.
Diabetes.
37:590-599.
1988
|
|
| 1988
|
Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus.
Journal of Clinical Investigation.
81:1528-1536.
1988
|
|
| 1987
|
Case report 417
1987
|
|
| 1987
|
Case report 417
1987
|
|
| 1987
|
Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance.
Journal of Biological Chemistry.
262:189-197.
1987
|
|
| 1987
|
Human adipocyte glucose transport system. Biochemical and functional heterogeneity of hexose carriers.
Journal of Clinical Investigation.
79:703-709.
1987
|
|
| 1987
|
Shunting of insulin from a retroendocytotic pathway to a degradative pathway by sodium vanadate.
Journal of Biological Chemistry.
262:12005-12012.
1987
|
|
| 1987
|
Xanthogranulomatosis in an adult: Lipid analysis of xanthomas and plasma.
Journal of the American Academy of Dermatology.
16:183-187.
1987
|
|
| 1987
|
Xanthogranulomatosis in an adult: lipid analysis of xanthomas and plasma..
Journal of the American Academy of Dermatology.
16:183-187.
1987
|
|
| 1986
|
Insulin induces progressive insulin resistance in cultured rat adipocytes: Sequential effects at receptor and multiple postreceptor sites.
Diabetes.
35:258-267.
1986
|
|
| 1985
|
Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes.
Journal of Clinical Investigation.
76:22-30.
1985
|
|
| 1985
|
Insulin resistance in non-insulin dependent (type II) and insulin dependent (type I) diabetes mellitus..
Advances in Experimental Medicine and Biology.
189:176-205.
1985
|
|
| 1985
|
Modulation of insulin secretion by insulin and glucose in type II diabetes mellitus.
Journal of Clinical Endocrinology and Metabolism.
60:559-568.
1985
|
|
| 1985
|
The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.
Diabetes.
34:222-234.
1985
|
|
| 1984
|
Primary culture of isolated adipocytes. A new model to study insulin receptor regulation and insulin action.
Journal of Biological Chemistry.
259:6376-6384.
1984
|
|
| 1978
|
In vitro vitamin K-dependent conversion of precursor to prothrombin in chick liver
1978
|
|
